Intestinal metaplasia

Intestinal metaplasia
Histopathology of Barrett's esophagus, showing intestinalized epithelium with goblet cells, as opposed to normal stratified squamous epithelium of the esophagus, and pseudostratified columnar epithelium of the fundus of the stomach. H&E stain.

Intestinal metaplasia is the transformation (metaplasia) of epithelium (usually of the stomach or the esophagus) into a type of epithelium resembling that found in the intestine. In the esophagus, this is called Barrett's esophagus. Chronic inflammation caused by H. pylori infection in the stomach and GERD in the esophagus are seen as the primary instigators of metaplasia and subsequent adenocarcinoma formation. Initially, the transformed epithelium resembles the small intestine lining; in the later stages it resembles the lining of the colon. It is characterized by the appearance of goblet cells and expression of intestinal cell markers such as the transcription factor, CDX2.

Risk factors

Although it was originally reported that people of East Asian ethnicity with gastric intestinal metaplasia are at increased risk of stomach cancer,[1] it is now clear that gastric intestinal metaplasia is also a risk factor in low-incidence regions like Europe.[2] Risk factors for progression of gastric intestinal metaplasia to full blown cancer are smoking and family history.[3]

References

  1. ↑ Choi, AY; Strate, LL; Fix, MC; Schmidt, RA; Ende, AR; Yeh, MM; Inadomi, JM; Hwang, JH (April 2018). "Association of gastric intestinal metaplasia and East Asian ethnicity with the risk of gastric adenocarcinoma in a U.S. population". Gastrointestinal Endoscopy. 87 (4): 1023–1028. doi:10.1016/j.gie.2017.11.010. PMID 29155082.
  2. ↑ den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MC (April 2019). "Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions". Gut. 68 (4): 585–593. doi:10.1136/gutjnl-2017-314498. PMID 29875257. S2CID 46962160.
  3. ↑ Nieuwenburg SA, Mommersteeg MC, Eikenboom EL, Yu B, den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Burger JP, Bruno MJ, Fuhler GM, Peppelenbosch MP, Doukas M, Kuipers EJ, Spaander MC (March 2021). "Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions". Endosc Int Open. 9 (3): E297–E305. doi:10.1055/a-1314-6626. PMC 7892268. PMID 33655025.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.